Explore more publications!

Press Releases

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025
West Coast Health Alliance, WA DOH, and Leading National Medical Organizations Continue to Recommend Hepatitis B Vaccination for Newborns

West Coast Health Alliance, WA DOH, and Leading National Medical Organizations Continue to Recommend Hepatitis B Vaccination for Newborns

WCHA, DOH, LEADING NATIONAL MEDICAL ORGANIZATIONS CONTINUE TO RECOMMEND HEPATITIS B VACCINATION FOR NEWBORNS

WCHA, DOH, LEADING NATIONAL MEDICAL ORGANIZATIONS CONTINUE TO RECOMMEND HEPATITIS B VACCINATION FOR NEWBORNS

SJSM Launches Tropical Medicine Pilot in Suriname, Prepares Students for Global Health
ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages aTyr Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - ATYR
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Meihua International Medical Technologies Co., Ltd. Received Nasdaq Delisting Notice
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Chartwell Pharmacy Becomes First Facility in US to Showcase EQUASHIELD’s Mundus Compounding System
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NASP Applauds the Senate Finance Committee for Legislation to Address Anticompetitive PBM Practices and Protect Pharmacies
Automated Pharmacy Compounding Systems Market Growing Toward USD 5.27 Billion in 2035

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions